EUVIMEDAtrasti EUVIMED
Multizentrische StudieKohortenstudieOpen access

Plasma Exchange in Myeloma‐Associated Acute Kidney Injury: A Multicenter Propensity‐Matched Cohort Study

Joseph O'Brien iD, Monica S Nair, Niraj B Desai, Robert W Maitta iD, Timothy O'Brien

Journal of Clinical Apheresis · 2026

DOI: 10.1002/jca.70167 ↗

At a glance

Multizentrische Studie in Journal of Clinical Apheresis, 2026. Written by Joseph O'Brien and 4 co-authors. Institution: Department of Emergency Medicine, Denver Health Medical Center, Denver, Colorado, USA. Major MEDLINE topics: Multiple Myeloma, Acute Kidney Injury, Plasma Exchange. Cited 1 times so far (Crossref); 19 references. The full text is freely available in PubMed Central.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Acute kidney failure from light chain cast nephropathy is a serious complication of multiple myeloma. Plasma exchange (PLEX) has been used to remove circulating free light chains (FLCs), but its benefit in the modern treatment era remains uncertain. We performed a retrospective multicenter cohort study using the TriNetX Research Network to identify newly diagnosed multiple myeloma cases presenting between 2014 and 2024 with acute kidney failure and FLC levels > 1500 mg/L. Patients were classified by receipt of PLEX within 7 days. Propensity score matching incorporated demographics, comorbidities, laboratory values, and initial myeloma‐directed therapies. The primary outcome was dialysis dependence at 90 days. Secondary outcomes included dialysis dependence at 180 days, mortality, renal recovery (creatinine < 2.0 mg/dL), ICU admission within 7 days, and dialysis‐free survival. Among 5454 eligible patients, 251 (4.6%) received PLEX. After matching, 248 patients were included in each group. PLEX was not associated with reduced dialysis dependence at 90 (16.1% vs. 18.1%; OR 0.87, 95% CI 0.54–1.39) or 180 days (18.5% vs. 20.2%; OR 0.90, 95% CI 0.58–1.41). Mortality, ICU admission, and dialysis‐free survival were also similar. PLEX was not associated with improved dialysis independence or survival, supporting rapid initiation of effective anti‐myeloma therapy.

Subjects

MeSH terms (MEDLINE)

Multiple MyelomaAcute Kidney InjuryPlasma ExchangeHumansRetrospective StudiesFemaleMalePropensity ScoreAgedMiddle AgedCohort StudiesRenal DialysisImmunoglobulin Light Chains

Author keywords

acute kidney injurydialysisfree light chainslight chain cast nephropathymultiple myelomaplasma exchange

Substances

Immunoglobulin Light Chains

Authors and institutions

  • Department of Emergency Medicine, Denver Health Medical Center, Denver, Colorado, USA.
  • Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Division of Nephrology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Pathology, Division of Transfusion Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

ORCID profiles: Joseph O'Brien, Robert W Maitta

Cite

APA

O'Brien, J., Nair, M. S., Desai, N. B., Maitta, R. W., & O'Brien, T. (2026). Plasma Exchange in Myeloma‐Associated Acute Kidney Injury: A Multicenter Propensity‐Matched Cohort Study. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70167

Vancouver

O'Brien J, Nair MS, Desai NB, Maitta RW, O'Brien T. Plasma Exchange in Myeloma‐Associated Acute Kidney Injury: A Multicenter Propensity‐Matched Cohort Study. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70167

BibTeX
@article{OBrien2026,
  author = {O'Brien, Joseph and Nair, Monica S and Desai, Niraj B and Maitta, Robert W and O'Brien, Timothy},
  title = {Plasma Exchange in Myeloma‐Associated Acute Kidney Injury: A Multicenter Propensity‐Matched Cohort Study},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  doi = {10.1002/jca.70167}
}
Start for free →